Related references
Note: Only part of the references are listed.Sex Hormone Binding Globulin and Aging
J. D. Caldwell et al.
HORMONE AND METABOLIC RESEARCH (2009)
Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies
Fernando Rivadeneira et al.
NATURE GENETICS (2009)
FSHβ knockout mouse model: a decade ago and into the future
T. Rajendra Kumar
ENDOCRINE (2009)
Advances in male contraception
Stephanie T. Page et al.
ENDOCRINE REVIEWS (2008)
Molecular pathology of the FSH receptor: New insights into FSH physiology
G. Meduri et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2008)
Multiple genetic loci for bone mineral density and fractures
Unnur Styrkarsdottir et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
DXA scanning in clinical practice
A. El Maghraoui et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2008)
Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation
Jameel Iqbal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Patient variables impact lumbar spine dual energy X-ray absorptiometry precision
RD Blank et al.
OSTEOPOROSIS INTERNATIONAL (2006)
Hormone predictors of bone mineral density changes during the menopausal transition
MR Sowers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Pathogenesis of osteoporosis: concepts, conflicts, and prospects
LG Raisz
JOURNAL OF CLINICAL INVESTIGATION (2005)
Role of nuclear factor-κB in the immune system and bone
E Jimi et al.
IMMUNOLOGICAL REVIEWS (2005)
Genetic complexity of FSH receptor function
J Gromoll et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2005)
Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH:: a pharmacogenetic approach to controlled ovarian hyperstimulation
HM Behre et al.
PHARMACOGENETICS AND GENOMICS (2005)
Targeting gonadotropin receptor genes
N Danilovich et al.
ENDOCRINE (2005)
Human controlled ovarian hyperstimulation outcome is a polygenic trait
F de Castro et al.
PHARMACOGENETICS (2004)
Hypergonadotropic amenorrhea and bone density: new approach to an old problem
B Devleta et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2004)
TSH is a negative regulator of skeletal remodeling
E Abe et al.
CELL (2003)
Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone
F de Castro et al.
FERTILITY AND STERILITY (2003)
Control of osteoblast function and regulation of bone mass
S Harada et al.
NATURE (2003)
Osteoclast differentiation and activation
WJ Boyle et al.
NATURE (2003)
Effectiveness of alendronate treatment in postmenopausal women with osteoporosis: relationship with BsmI vitamin D receptor genotypes
S Palomba et al.
CLINICAL ENDOCRINOLOGY (2003)
Postendocytotic trafficking of the follicle-stimulating hormone (FSH)-FSH receptor complex
H Krishnamurthy et al.
MOLECULAR ENDOCRINOLOGY (2003)
Raloxifene administration in post-menopausal women with osteoporosis: effect of different BsmI vitamin D receptor genotypes
S Palomba et al.
HUMAN REPRODUCTION (2003)
Genetic and functional analyses of polymorphisms in the human FSH receptor gene
S Sudo et al.
MOLECULAR HUMAN REPRODUCTION (2002)
Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice
N Danilovich et al.
ENDOCRINOLOGY (2000)
Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype
MP Mayorga et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)